SILK Silk Road Medical, Inc.: Rasio utang marang kapitalisasi buku

Simbol resmi perusahaan Silk Road Medical, Inc (SILK)

High margins and patent protection create a stable cash flow, supporting the operational peak of Silk Road Medical, Inc (SILK). The debt-to-book capitalization trend on the GURU.Markets service demonstrates that the metric has reached the level of 0.59. Success is based on US-based production of TCAR systems and the absolute trust of surgeons in the safety of stroke prevention methods.

Silk Road Medical, Inc - Utang-utang marang kapitalisasi buku SILK (periode 04.07.2022 - 28.09.2024)
Sampel barang Silk Road Medical Inc

This ratio assesses the proportion of borrowed funds relative to equity, determining the company's financial autonomy. A decrease in this metric minimizes default risks, although a complete avoidance of loans limits growth rates. By analyzing the debt-to-equity coverage ratio, an investor can see the balance between stability and aggressive growth. For Silk Road Medical, Inc (SILK), this is critical when scaling the supply of minimally invasive surgery systems. An optimal debt level ensures the expansion of carotid artery treatment technologies without the threat of bankruptcy.

Perusahaan pesaing

Utang-utang marang kapitalisasi buku DXCM (DexCom, Inc.)|penumbrainc.com (PEN) - Utang-utang marang nilai buku|NOVT - Rasio utang marang kapitalisasi buku|Rasio utang marang aset resik HAE (Haemonetics Corp)|INSP: Utang-utang marang kapitalisasi buku|Procept (PRCT) - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku CONMED Corporation|pulsebiosciences.com - Rasio utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku INMD|PMI - Utang-utang marang nilai buku|Surmodics Corp - Utang marang nilai buku|Utang-utang marang kapitalisasi buku Senseonics SENS|NPCE: Utang marang nilai buku|Tactile Systems Technology - Utang marang modal buku|SNWV: Utang-utang marang kapitalisasi buku|OM - Utang-utang marang aset resik|ELMD (SmartVest) - Utang-utang marang kapitalisasi buku|Utang marang nilai buku LENSAR Inc (LNSR)|Utang marang nilai buku RCEL (AVITA Medical, Inc.)|PROF (profoundmedical.com) - Rasio utang marang aset resik|Rasio utang marang kapitalisasi buku Baird Medical BDMD|EDAP - Utang marang nilai buku|Bovie Medical - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku IceCure Medical Ltd|LUNG: Utang-utang marang kapitalisasi buku|Rasio utang marang nilai buku TELA|CTSO (CytoSorbents Corp) - Utang-utang marang kapitalisasi buku|Sensus Healthcare Inc (SRTS) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku ZYXI|Utang marang nilai buku electrocore.com ECOR|Utang-utang marang kapitalisasi buku RBOT (Vicarious Surgical)|Utang-utang marang kapitalisasi buku Inspira Technologies Oxy B.H.N. Ltd. IINN|ICU - Rasio utang marang kapitalisasi buku|IRIX: Rasio utang marang kapitalisasi buku|INBS (ibs.inc) - Utang marang nilai buku|Beyond Air - Rasio utang marang aset resik|PFSA (Profusa Inc) - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku STRATA Skin SSKN|Rasio utang marang kapitalisasi buku GlucoTrack (GCTK)|NanoVibronix Inc. (NAOV) - Utang marang aset resik|Venus Concept Corp - Utang marang nilai buku|Utang-utang marang kapitalisasi buku Nuwellis Corp NUWE|Aethlon Medical - Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik Asensus Surgical, Inc. ASXC|Avinger (AVGR) - Rasio utang marang kapitalisasi buku|Rasio utang-utang marang kapitalisasi buku BSGM (biosig.com)|Rasio utang marang kapitalisasi buku Cutera, Inc|Utang marang nilai buku Know Labs Corporation (KNW)|Utang-utang marang kapitalisasi buku NARI|NVRO - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku ReShape Lifesciences Inc. RSLS